Goals: To evaluate provider knowledge, attitudes and barriers to hepatitis B virus (HBV) care and management practices across diverse primary care settings.
C hronic hepatitis B virus (HBV) infection poses a significant public health burden, affecting 350 million individuals worldwide, with 1.25 to 2.2 million carriers in the United States alone. 1, 2 Complications of HBV include development of cirrhosis, fulminant liver failure, and hepatocellular carcinoma (HCC). 3, 4 It is estimated that nearly 20% of patients with chronic HBV will die from complications of liver disease. 5 Therefore, screening practices are essential to ensure early patient identification and prompt treatment initiation.
As of 2014, the United States Preventive Services Task Force recommends HBV screening in persons considered "high risk" for infection. 6 This recommendation is now in line with the American Association for the Study of Liver Diseases (AASLD) and the Center for Disease Control and Prevention guidelines. 2, 7 Aside from individuals from endemic areas (prevalence Z2%), those who practice risky behaviors (injection drug users, multiple sexual partners, men who have sex with men) and have potential exposure to HBV (household contacts, health care workers) are considered high risk. 6 According to AASLD, both HBV surface antigen (HBsAg) and antibody (anti-HBs) tests should be obtained to both screen for and assess HBV vaccination eligibility. 2 Interval monitoring of alanine aminotransferase (ALT) levels and HBV viral load are also recommended to help monitor disease course and identify those eligible for treatment initiation. 2 HBV poses a major health disparity in the United States, with many infected individuals being from predominantly immigrant, underinsured, and low-income communities. [8] [9] [10] Asian and Pacific Islanders (API) are a particularly vulnerable population, with disproportionately high rates of HBV infection. The San Francisco Bay Area is home to one of the largest API populations in the United States, and it is estimated that B9% of API in this region have chronic HBV. 11 Previously, our group has published on HBV screening practices among providers of a San Francisco safety net health care system that serves uninsured and underinsured populations. [12] [13] [14] We showed that among APIs, < two thirds underwent HBV testing and <50% of susceptible patients were vaccinated for HBV. 12 Moreover, based on self-report, over 40% of providers were unfamiliar with HBV screening guidelines. 13 With the recent enactment of the Affordable Care Act, public and private health systems alike are faced with treating the previously underinsured populations with HBV. As such, it has become important to understand provider knowledge and approach to HBV in this vulnerable population in an effort to minimize health disparity. The aim of this study is to describe provider practices, as well as knowledge, attitudes, and barriers to the prevention and management of HBV in a diverse patient population across a broad spectrum of health care systems. The survey was sent to providers by postal or electronic mail and a subsequent mailing to nonrespondents was conducted after 4 weeks. Provider responses were deidentified for data analysis.
MATERIALS AND METHODS

Provider Survey
The survey instrument was developed by study investigators with input from experts in primary care, hepatology, survey design, and using a previously published related survey. 14 Content domains included provider, practice and patient characteristics; HBV screening, vaccination, and management practices; familiarity with HBV management guidelines; HCC screening practices including modalities used; and provider attitudes about and perceived barriers toward HBV care. The survey was pilot tested with 20 physicians and revised based on their feedback.
Data Analysis
Provider characteristics-demographic, training and experience, and practice features-are described using frequencies, overall and by setting. To assess overall provider knowledge, favorable attitudes, and barriers to HBV care, the percent correct (for knowledge items) and percent agreeing (for attitude and barrier items) for each question was calculated. For use in multivariable models, individual providers' composite scores were formed from responses to these questions. Specifically, the knowledge score was computed as the number of correct responses to eleven questions assessing knowledge (1 for correct, 0 for incorrect; maximum score 11). The attitude score was determined by summing the numerical codes assigned to responses to 8 questions designed to assess attitudes (1 for "agree" response, 0.5 for "unsure" response, and 0 for "disagree" response; maximum score 8). The barrier score was also determined by summing the numerical codes for 9 questions regarding perceived barriers in their practice (1 for "agree" response, 0.5 for "unsure" response, and 0 for "disagree" response; maximum score 9). Higher composite scores represent higher knowledge, favorable attitude, and greater barriers to HBV care. The three mean ± SD composite scores were calculated and also expressed as mean percentages.
Seventy-five percent of providers reported all 18 characteristics and only 5% omitted more than 3. SAS proc MI was used to generate 5 replicate datasets with imputed missing values. Multivariable forward stepwise regression modeling through SAS proc logistic (adjusted for provider age, gender, Asian race, and provider patient load, and stratified by dataset) was used to identify which of the 14 other provider characteristics are significantly associated with each of the 4 outcomes-HBV screening, vaccination, disease monitoring and HCC surveillance-with SAS proc mianalyze used to estimate the mean results across the 5 replicate datasets. The four binary outcome measures indicated providers' self-reported performance of: (1) recommended HBV screening, defined as use of both HBsAg and anti-HBs, (2) HBV vaccination in >50% of vaccineeligible patients, (3) recommended HBV disease monitoring in those with chronic HBV, defined as use of ALT every 6 months and HBV DNA every 6 to 12 months, and (4) recommended HCC surveillance in eligible patients with chronic HBV, defined as performing abdominal ultrasound every 6 months. All analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC).
RESULTS
A total of 671 providers were sampled, with 277 respondents (148 from the safety net and 129 from nonsafety net systems) for a response rate of 41.3%. The majority of providers were female, held a doctor of medicine (MD) degree, and approximately half self-identified as White and one third, API (Table 1) . Over 40% of providers were in practice for over 10 years, and approximately half of providers served a patient panel comprised of over 25% Asians and also patients with limited English proficiency. Half of the practices served patients with a significant proportion of patients that were uninsured or underinsured, with the majority of these providers (91%) practicing in the safety net setting.
Although 40% of providers felt they were unfamiliar with AASLD guidelines for HBV management (48% somewhat familiar and 7% very familiar), overall provider knowledge scores were favorable (Supplemental Table 1 , Supplemental Digital content 1, http://links.lww.com/JCG/ A290). However, nearly a third of providers were not aware that high levels of HBV viral load are associated with an increased incidence of cirrhosis and that HBV-induced liver cancer can occur in the absence of cirrhosis. Moreover, one third of providers thought that all patients with hepatitis B should be treated, suggesting a lack of familiarity with treatment eligibility criteria. However, providers were motivated to screen for HBV when it was evidence driven, recommended by a national organization, and if it was used as a quality measure by their institution or insurance companies. The most commonly cited barriers to HBV screening were lack of clarity of guidelines, uncertainty or unawareness of guidelines, and patient financial barriers.
HBV screening rates of >50% among their at-risk adult patients. For HBV testing, 95% of providers used HBsAg, with 78% ordering both HBsAg and anti-HBs (with or without anti-HBc); 16% did not include anti-HBs as part of their screening. Only half of providers reported vaccinating >50% of eligible patients, and 19% of providers reported vaccinating >75% of their eligible patients against HBV.
HBV Management Practices Based on Provider Self-Report
Provider self-reported management practices of HBVinfected patients are shown in Figure 2 . With respect to monitoring of HBV disease activity ( Fig. 2A) , the majority of providers reported appropriate monitoring of ALT and HBV viral load every 6 to 12 months in their HBV-infected population; ALT levels were most often monitored every 6 months and HBV viral load levels were most often monitored every 12 months. However, hepatitis B E-antigen testing was less frequently performed or not performed at all as part of HBV disease monitoring. More than 70% of providers performed hepatitis A virus vaccination and testing for hepatitis C virus coinfection in >50% of their HBV-infected patients (Fig. 2B) . Treatment for HBV infection was offered by only 16% of primary providers. Although most providers performed HCC surveillance, only half performed HCC surveillance in >75% of HBVinfected patients (Fig. 2B) . The type and frequency of HCC screening tests used by providers are shown in Figure 3 . As shown, alpha-fetoprotein and abdominal ultrasound were the most frequent HCC screening modalities used, but a small proportion reported using computed tomography or magnetic resonance imaging scans.
Factors Associated With HBV Screening and Vaccination
On multivariate analysis adjusted for provider age, gender, race, and patient load in practice (Table 2) , HBV screening was positively associated with provider speaking an Asian language [odds ratio (OR), 3.27; 95% confidence interval (CI), 1.19-8.96; P = 0.021], offering HBV treatment within their clinical practice (OR, 3.00; 95% CI, 1.34-6.72; P = 0.0076), and serving a patient panel with >25% API patients (OR, 2.10; 95% CI, 1.07-4.09; P = 0.030) and negatively associated with a higher provider barrier score (OR, 0.74; 95% CI, 0.57-0.96; P = 0.025). Moreover, practicing in the safety net setting was associated with about 7 times higher odds of screening for HBV (OR, 7.51; 95% CI, 3.75-15.07; P < 0.0001). With respect to HBV vaccination, offering HBV treatment in practice and serving a patient panel of >25% APIs were positively associated, while provider being foreign-born was negatively associated with HBV vaccination.
Factors Associated With Recommended HBV Monitoring and HCC Surveillance in HBVinfected Patients
On multivariable analysis adjusted for provider age, gender, race, and patient load in practice (Table 2) , the only factor with a positive significant association with performing recommended HBV monitoring was provider speaking an Asian language (OR, 3.43; 95% CI, 1.38-8.53; P = 0.0081), whereas provider age (OR per decade, 0.68; 95% CI, 0.53-0.87; P = 0.0026) was negatively associated. Serving a patient panel with >25% patients speaking English as a second language (OR, 4.26; 95% CI, 1.76-10.30; P = 0.0013) was positively associated with performing appropriate HCC surveillance, whereas practicing within the safety net setting (OR, 0.14; 95% CI, 0.05-0.41; P < 0.001) was negatively associated.
DISCUSSION
This study provides insight into HBV preventive and management practices among primary care providers across a broad spectrum of health care settings serving an urban population. Provider reported rates of HBV screening and vaccination and HCC surveillance among eligible HBVinfected patients were suboptimal. We found that in addition to patient and practice factors, certain provider factors, including provider age, foreign birth, speaking an Asian language and perceived barriers to HBV care, were associated with HBV prevention and management practices. Moreover, practicing in the safety net health care system was strongly associated with HBV screening, but was negatively associated with performing recommended HCC surveillance.
The prevalence of HBV varies nationwide largely as a function of immigration patterns, and nearly one fourth of the San Francisco Bay area population is from endemic Asian and Pacific Island regions. 15 Motivated by high rates of undiagnosed chronic HBV infection in the API population, community efforts through the "Hepatitis B Free" Campaign were launched, possibly resulting in a heightened awareness among both providers and patients in the city. 16, 17 Indeed, in this study, providers serving a large API population in practice had an increased odds of performing HBV screening and vaccination, irrespective of health care setting or medical group affiliation. Moreover, providers that spoke an Asian language had an increased odds of performing both HBV screening and appropriate HBV monitoring. In addition, practicing in the safety net setting was also independently associated with higher odds of HBV screening which may in part be related to the exposure of providers to a high proportion of at-risk immigrant populations served in this network.
However, despite these community efforts, self-reported HBV prevention and management practices were suboptimal, and this study highlights several gaps in provider knowledge. Nearly half of providers were unfamiliar with current AASLD guidelines for the management of HBV that includes liver cancer screening. 2 Notably, a third of providers were unaware that HBV therapy reduces the risk for liver disease progression, whereas a similar proportion reported that all patients with HBV should be treated, both suggesting a lack of familiarity with indications for HBV treatment. Approximately 15% of providers did not evaluate for evidence of immunity in at-risk populations, which represents a missed opportunity to identify vaccine-eligible patients served by these providers. Moreover, many providers were unaware that HBV infection can induce HCC development in the absence of cirrhosis, highlighting limited awareness of HCC screening guidelines. Greater collaboration between primary care providers and liver disease specialists in developing and distributing evidence-based guidelines attuned to the context of primary care practice may help to address these gaps in knowledge and potentially improve HBV prevention and management in primary care practices.
Several factors apart from provider knowledge also appear to influence HBV practice patterns. Provider perceived barriers to HBV care have a clear impact on HBV prevention in this study, as a higher perceived barrier score was associated with a 25% reduction in the odds of performing HBV screening. In addition, practicing in the safety net setting was negatively associated with HCC surveillance, and this may indeed be a reflection of perceived barriers, particularly resource constraints such as access to abdominal imaging. These findings highlight that in addition to provider education, addressing provider perceived barriers to HBV care is critical. Provider foreign birth and older age were also negative predictors of HBV vaccination and HBV monitoring, respectively. Although the reasons for these associations are not known and may be related to unmeasured factors, these findings suggest that targeted intervention among these provider groups is warranted.
The findings of this study support the notion that a complex interplay of factors shape HBV care and additional systematic quality improvement strategies to implement guideline-driven HBV recommendations represent an important strategy to improve HBV care. This approach was recently demonstrated by the Northern California Kaiser Permanente group, who developed a HBV Liver Care Program that was informed by the finding of suboptimal adherence to HBV guidelines in a large cohort of HBV patients. 18 The program uses many elements of the Chronic Care Model, 19 such as a registry of infected patients, automated reminders to patients to perform recommended tests, and access to a dedicated care team that can order tests and administer therapy when indicated. Although data regarding the impact of this intervention are currently not available, it is hoped that similar implementation of systematic solutions at the institutional level may help improve management of patients with HBV.
A strength of this study is the evaluation of provider knowledge, attitudes, and barriers to HBV care among a large number of primary care providers across diverse health care settings in an urban area, including those serving privately and publicly insured and uninsured populations. The limitations of the study include use of provider selfreport and survey response rates of 40%, though this response rate is comparable with other previously reported provider survey studies. 13, 20, 21 Provider self-report tends to overestimate adherence to quality of care guidelines. 22 However, the suboptimal rates of HBV screening, HBV vaccination, and HCC surveillance observed in this study suggest that many providers candidly acknowledged that they did not consistently implement screening and management practices for all appropriate patients. Moreover, in a previously published study of providers and patients in the San Francisco safety net, we found that provider self-report of HBV screening and immunization practices generally aligned with objective measures of clinical practice derived from electronic medical record data, adding further value to these findings. 12 The generalizability of our findings may be limited by the possible heightened awareness of HBV among providers and patients in the San Francisco bay area as a result of community outreach efforts. However, the fact that HBV prevention and management practices remained suboptimal suggests that these efforts alone do not address the gaps in HBV care and reflects a potential for even higher gaps in HBV care in other regions of the country. In summary, certain provider, patient, and practice factors influence HBV prevention and management practices in primary care settings. Rates of adherence to HBV screening and management guidelines appear to be suboptimal for this group of providers irrespective of practice setting. This study highlights the importance of engaging primary care providers in development, dissemination, and implementation of evidence-based HBV guidelines and identifies important topic areas and provider groups for targeted educational efforts. Given the complex interplay of factors influencing HBV care, implementation of systematic HBV quality improvement initiatives may help improve HBV prevention and care.
